An AI-designed obesity drug targeting the GIP receptor shows over 31% weight loss in preclinical tests, raising hopes for ...

By Tarun Sai Lomte Emerging research suggests certain dietary compounds may strengthen the body’s defences against ...

Willpower is not purely a personality trait. Aging, obesity, insulin resistance, and inflammation may impair frontal brain ...

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, ...

Obesity is an independent driver of cardiovascular disease (CVD), mediated through adverse haemodynamic loading, insulin resistance, systemic inflammation, endothelial dysfunction and prothrombotic ...

Pramorelin, also known in scientific literature as a synthetic ghrelin receptor agonist, has emerged as a notable peptide within the broader landscape of endocrine and metabolic research. Its primary ...

Saturated fats are often discussed mainly for their role in raising LDL cholesterol, but research shows their metabolic ...

Study finds weight loss results drive continued Ozempic use despite nausea and other side effects, based on real world ...

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much ...

Although a growing body of evidence suggests a positive impact of GLP-1 receptor agonists in treating MS, questions of health ...

DuBois, PA / Syndication Cloud / February 20, 2026 / Mercy Family Health and Pain Management Key Takeaways Processing ...

Diabetes mellitus, particularly type 2 diabetes, is associated with an increased risk of several malignancies, raising important questions at the interface ...